Physical inactivity and muscle weakness in the critically ill

Critical Care Medicine

Volumn 37, Issue SUPPL. 10, 2009, Pages

  Chambers, Melissa A ^a   Moylan, Jennifer S ^a   Reid, Michael B ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atrophy; Bed rest; Cachexia; Catabolism; Critical illness myopathy; Frailty; Microgravity; Rehabilitation; Skeletal muscle; Strength

Indexed keywords

ATROGIN 1; CALPAIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN H; CATHEPSIN L; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C;

APOPTOSIS; AUTOPHAGY; BED REST; CONFERENCE PAPER; CRITICALLY ILL PATIENT; IMMOBILIZATION; INTENSIVE CARE UNIT; MUSCLE ATROPHY; MUSCLE WEAKNESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

EID: 70350520677     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b6e974     Document Type: Conference Paper

References (108)

1. Adams GR, Caiozzo VJ, Baldwin KM: Skeletal muscle unweighting: Spaceflight and ground-based models. J Appl Physiol 2003; 95:2185-2201
2. Morey-Holton ER, Globus RK: Hindlimb unloading rodent model: Technical aspects. J Appl Physiol 2002; 92:1367-1377
3. Jaspers SR, Tischler ME: Atrophy and growth failure of rat hindlimb muscles in tail-cast suspension. J. Appl Physiol 1984; 57:1472-1479
4. 4. Booth FW, Seider MJ: Recovery of skeletal muscle after 3 mo of hindlimb immobilization in rats. J Appl Physiol 1979; 47: 435-439 (Pubitemid 10109507)
5. Goldspink DF: The effects of denervation on protein turnover of rat skeletal muscle. Biochem J 1976; 156:71-80
6. 6. Dupont-Versteegden EE, Houle JD, Gurley CM, et al: Early changes in muscle fiber size and gene expression in response to spinal cord transection and exercise. Am J Physiol 1998; 275:C1124-C1133 (Pubitemid 28491806)
7. 7. Bajotto G, Shimomura Y: Determinants of disuse-induced skeletal muscle atrophy: Exercise and nutrition countermeasures to prevent protein loss. J Nutr Sci Vitaminol (Tokyo) 2006; 52:233-247 (Pubitemid 44520051)
8. 8. Powers SK, Kavazis AN, McClung JM: Oxidative stress and disuse muscle atrophy. J Appl Physiol 2007; 102:2389-2397 (Pubitemid 47080773)
9. Reid CL, Campbell IT, Little RA: Muscle wasting and energy balance in critical illness. Clin Nutr 2004; 23:273-280
10. 10. Helliwell TR, Wilkinson A, Griffiths RD, et al: Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol 1998; 24:507-517 (Pubitemid 29002282)
11. 11. Arbogast S, Smith J, Matuszczak Y, et al: Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimbunloaded mice. J Appl Physiol 2007; 102: 956-964 (Pubitemid 46377018)
12. 12. Matuszczak Y, Arbogast S, Reid MB: Allopurinol mitigates muscle contractile dysfunction caused by hindlimb unloading in mice. Aviat Space Environ Med 2004; 75: 581-588 (Pubitemid 38857377)
13. 13. LeBlanc A, Gogia P, Schneider V, et al: Calf muscle area and strength changes after five weeks of horizontal bed rest. Am J Sports Med 1988; 16:624-629 (Pubitemid 19022502)
14. Berg HE, Dudley GA, Haggmark T, et al: Effects of lower limb unloading on skeletal muscle mass and function in humans. J Appl Physiol 1991; 70:1882-1885
15. Riley DA, Bain JL, Thompson JL, et al: Decreased thin filament density and length in human atrophic soleus muscle fibers after spaceflight. J Appl Physiol 2000; 88: 567-572
16. 16. Choi I, Lee K, Kim M, et al: Differential activation of stress-responsive signalling proteins associated with altered loading in a rat skeletal muscle. J Cell Biochem 2005; 96:1231-1243 (Pubitemid 41681865)
17. Lacomis D: Critical illness myopathy. Curr Rheumatol Rep 2002; 4:403-408
18. 18. Stibler H, Edstrom L, Ahlbeck K, et al: Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 2003; 9:1515-1527 (Pubitemid 37153596)
19. Thomason DB, Biggs RB, Booth FW: Protein metabolism and beta-myosin heavychain mRNA in unweighted soleus muscle. Am J Physiol 1989; 257:R300-305
20. Reynolds THt, Bodine SC, Lawrence JC Jr: Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 2002; 277:17657-17662
21. Hay N, Sonenberg N: Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926-1945
22. 22. Hornberger TA, Hunter RB, Kandarian SC, et al: Regulation of translation factors during hindlimb unloading and denervation of skeletal muscle in rats. Am J Physiol Cell Physiol 2001; 281:C179-C187 (Pubitemid 32927328)
23. 23. Philippou A, Halapas A, Maridaki M, et al: Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact 2007; 7:208-218 (Pubitemid 350238147)
24. 24. Awede B, Thissen J, Gailly P, et al: Regulation of IGF-I, IGFBP-4 and IGFBP-5 gene expression by loading in mouse skeletal muscle. FEBS Lett 1999; 461:263-267 (Pubitemid 29533344)
25. Han B, Zhu MJ, Ma C, et al: Rat hindlimb unloading down-regulates insulin like growth factor-1 signaling and AMP-activated protein kinase, and leads to severe atrophy of the soleus muscle. Appl Physiol Nutr Metab 2007; 32:1115-1123
26. 26. Jakobsen SN, Hardie DG, Morrice N, et al: 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole4-carboxamide riboside. J Biol Chem 2001; 276:46912-46916 (Pubitemid 37373061)
27. 27. Taillandier D, Aurousseau E, Meynial-Denis D, et al: Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 1996; 316:65-72 (Pubitemid 126732838)
28. Goll DE, Thompson VF, Li H, et al: The calpain system. Physiol Rev 2003; 83: 731-801
29. Tallant EA, Brumley LM, Wallace RW: Activation of a calmodulin-dependent phosphatase by a Ca2+-dependent protease. Biochemistry 1988; 27:2205-2211
30. 30. Solomon V, Goldberg AL: Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 1996; 271:26690-26697 (Pubitemid 26359075)
31. 31. Purintrapiban J, Wang MC, Forsberg NE: Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells. Comp Biochem Physiol B Biochem Mol Biol 2003; 136:393-401 (Pubitemid 37352961)
32. Ke L, Qi XY, Dijkhuis AJ, et al: Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation. J Mol Cell Cardiol 2008; 45:685-693
33. 33. Tischler ME, Rosenberg S, Satarug S, et al: Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle. Metabolism 1990; 39:756-763 (Pubitemid 20198271)
34. 34. Enns DL, Raastad T, Ugelstad I, et al: Calpain/calpastatin activities and substrate depletion patterns during hindlimb unweighting and reweighting in skeletal muscle. Eur J Appl Physiol 2007; 100:445-455 (Pubitemid 46773994)
35. Ikemoto M, Nikawa T, Takeda S, et al: Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J 2001; 15: 1279-1281
36. Tidball JG, Spencer MJ: Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 2002; 545:819-828
37. 37. Servais S, Letexier D, Favier R, et al: Prevention of unloading-induced atrophy by vitamin E supplementation: Links between oxidative stress and soleus muscle proteolysis? Free Radic Biol Med 2007; 42:627-635 (Pubitemid 46210130)
38. 38. Reid MB: Response of the ubiquitinproteasome pathway to changes in muscle activity. Am J Physiol Regul Integr Comp Physiol 2005; 288:R1423-R1431 (Pubitemid 40720691)
39. 39. Riley DA, Ilyina-Kakueva EI, Ellis S, et al: Skeletal muscle fiber, nerve, and blood vessel breakdown in space-flown rats. FASEB J 1990; 4:84-91 (Pubitemid 20043132)
40. 40. Bodine SC, Latres E, Baumhueter S, et al: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704-1708 (Pubitemid 33104839)
41. Nikawa T, Ishidoh K, Hirasaka K, et al: Skeletal muscle gene expression in spaceflown rats. FASEB J 2004; 18:522-524
42. Gomes MD, Lecker SH, Jagoe RT, et al: Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98: 14440-14445
43. Jones SW, Hill RJ, Krasney PA, et al: Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J 2004; 18: 1025-1027
44. Csibi A, Leibovitch MP, Cornille K, et al: MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines. J Biol Chem 2009; 284:4413-4421. Epub 2008 Dec 10
45. Murtón AJ, Constantin D, Greenhaff PL: The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008; 1782:730-743
46. 46. Brunet A, Bonni A, Zigmond MJ, et al: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96:857-868 (Pubitemid 29165088)
47. O'Keefe MP, Perez FR, Sloniger JA, et al: Enhanced insulin action on glucose transport and insulin signaling in 7-day unweighted rat soleus muscle. J Appl Physiol 2004; 97:63-71
48. 48. Sugiura T, Abe N, Nagano M, et al: Changes in PKB/Akt and calcineurin signaling during recovery in atrophied soleus muscle induced by unloading. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1273-R1278 (Pubitemid 40593711)
49. 49. Hunter RB, Stevenson E, Koncarevic A, et al: Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 2002; 16:529-538 (Pubitemid 34273236)
50. Morris RT, Spangenburg EE, Booth FW: Responsiveness of cell signaling pathways during the failed 15-day regrowth of aged skeletal muscle. J Appl Physiol 2004; 96: 398-404
51. 51. Li YP, Lecker SH, Chen Y, et al: TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 2003; 17:1048-1057 (Pubitemid 36676391)
52. Li H, Malhotra S, Kumar A: Nuclear factorkappa B signaling in skeletal muscle atrophy. J Mol Med 2008; 86:1113-1126
53. 53. Farid M, Reid MB, Li YP, et al: Effects of dietary curcumin or N-acetylcysteine on NF-kappaB activity and contractile performance in ambulatory and unloaded murine soleus. Nutr Metab (Lond) 2005; 2:20 (Pubitemid 41317459)
54. Hunter RB, Kandarian SC: Disruption of either the Nfkbl or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 2004; 114:1504-1511
55. 55. Judge AR, Koncarevic A, Hunter RB, et al: Role for IkappaBalpha, but not c-Rel, in skeletal muscle atrophy. Am J Physiol Cell Physiol 2007; 292:C372-C382 (Pubitemid 46115145)
56. 56. Cai D, Frantz JD, Tawa NE Jr, et al: IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004; 119: 285-298 (Pubitemid 39360909)
57. Wyke SM, Russell ST, Tisdale MJ: Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation. Br J Cancer 2004; 91:1742-1750
58. 58. Li YP, Chen Y, Li AS, et al: Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003; 285: C806-C812 (Pubitemid 37158805)
59. 59. Lawler JM, Song W, Demaree SR: Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Radic Biol Med 2003; 35:9-16 (Pubitemid 36782333)
60. Siu PM, Pistilli EE, Alway SE: Agedependent increase in oxidative stress in gastrocnemius muscle with unloading. J Appl Physiol 2008; 105:1695-1705
61. 61. Guillot C, Steinberg JG, Delliaux S, et al: Physiological, histological and biochemical properties of rat skeletal muscles in response to hindlimb suspension. J Electromyogr Kinesiol 2008; 18:276-283 (Pubitemid 351200046)
62. 62. Li YP, Chen Y, John J, et al: TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atroginl/MAFbx in skeletal muscle. FASEB J 2005; 19:362-370 (Pubitemid 40316524)
63. Bechet D, Tassa A, Taillandier D, et al: Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol 2005; 37:2098-2114
64. Katunuma N, Kominami E: Structures and functions of lysosomal thiol proteinases and their endogenous inhibitor. Curr Top Cell Regul 1983; 22:71-101
65. Schwartz W, Bird JW: Degradation of myofibrillar proteins by cathepsins B and D. Biochem J 1977; 167:811-820
66. 66. Noda T, Isogai K, Hayashi H, et al: Susceptibilities of various myofibrillar proteins to cathepsin B and morphological alteration of isolated myofibrils by this enzyme. J Biochem 1981; 90:371-379 (Pubitemid 11012617)
67. 67. Matsukura U, Okitani A, Nishimuro T, et al: Mode of degradation of myofibrillar proteins by an endogenous protease, cathepsin L. Biochim Biophys Acta 1981; 662:41-47 (Pubitemid 12216171)
68. 68. Taillandier D, Aurousseau E, Combaret L, et al: Regulation of proteolysis during reloading of the unweighted soleus muscle. Int J Biochem Cell Biol 2003; 35:665-675 (Pubitemid 36369514)
69. 69. Sandri M: Apoptotic signaling in skeletal muscle fibers during atrophy. Curr Opin Clin Nutr Metab Care 2002; 5:249-253 (Pubitemid 40684669)
70. Primeau AJ, Adhihetty PJ, Hood DA: Apoptosis in heart and skeletal muscle. Can J Appl Physiol 2002; 27:349-395
71. Ferreira R, Neuparth MJ, Vitorino R, et al: Evidences of apoptosis during the early phases of soleus muscle atrophy in hindlimb suspended mice. Physiol Res 2008; 57: 601-611
72. 72. Leeuwenburgh C, Gurley CM, Strotman BA, et al: Age-related differences in apoptosis with disuse atrophy in soleus muscle. Am J Physiol Regul Integr Comp Physiol 2005; 288:R1288-R1296 (Pubitemid 40593713)
73. Chen M, Won DJ, Krajewski S, et al: Calpain and mitochondria in ischemia/reperfusion injury. J Biol Chem 2002; 277:29181-29186
74. 74. Kujawa M, Baran W, Jankowska-Steifer E: Quantitative ultrastructural changes in satellite cells of rats immobilized after soleus muscle denervation. Exp Mol Pathol 2005; 78:78-85 (Pubitemid 41373321)
75. Siu PM, Pistilli EE, Alway SE: Apoptotic responses to hindlimb suspension in gastrocnemius muscles from young adult and aged rats. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1015-R1026
76. Smith MA, Reid MB: Redox modulation of contractile function in respiratory and limb skeletal muscle. Respir Physiol Neurobiol 2006; 151:229-241
77. Reid MB: Invited review: Redox modulation of skeletal muscle contraction: What we know and what we don't. J Appl Physiol 2001; 90:724-731
78. 78. Kondo H, Nakagaki I, Sasaki S, et al: Mechanism of oxidative stress in skeletal muscle atrophied by immobilization. Am J Physiol 1993; 265:E839-E844 (Pubitemid 24030395)
79. Pizza FX, Hernandez IJ, Tidball JG: Nitric oxide synthase inhibition reduces muscle inflammation and necrosis in modified muscle use. J Leukoc Biol 1998; 64: 427-433
80. 80. Suzuki N, Motohashi N, Uezumi A, et al: NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 2007; 117: 2468-2476 (Pubitemid 47494348)
81. 81. Kandarian SC, Stevenson EJ: Molecular events in skeletal muscle during disuse atrophy. Exerc Sport Sci Rev 2002; 30: 111-116 (Pubitemid 34787297)
82. Hamilton SL, Reid MB: RyRl modulation by oxidation and calmodulin. Antioxid Redox Signal 2000; 2:41-45
83. Viner RI, Ferrington DA, Aced GI, et al: In vivo aging of rat skeletal muscle sarcoplasmic reticulum Ca-ATPase. Chemical analysis and quantitative simulation by exposure to low levels of peroxyl radicals. Biochim Biophys Acta 1997; 1329:321-335
84. 84. Siems W, Capuozzo E, Lucano A, et al: High sensitivity of plasma membrane ion transport ATPases from human neutrophils towards 4-hydroxy-2,3-trans-nonenal. Life Sci 2003; 73:2583-2590 (Pubitemid 37098298)
85. 85. Kabe Y, Ando K, Hirao S, et al: Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005; 7:395-403 (Pubitemid 40279807)
86. Needham DM: Mobilizing patients in the intensive care unit: Improving neuromuscular weakness and physical function. JAMA 2008; 300:1685-1690
87. 87. Tada O, Yokogoshi H: Effect of different dietary protein composition on skeletal muscle atrophy by suspension hypokinesia/hypodynamia in rats. J Nutr Sci Vitaminol (Tokyo) 2002; 48:115-119 (Pubitemid 34733442)
88. 88. Ikemoto M, Nikawa T, Kano M, et al: Cysteine supplementation prevents unweighting-induced ubiquitination in association with redox regulation in rat skeletal muscle. Biol Chem 2002; 383:715-721 (Pubitemid 34506309)
89. Stein TP, Schluter MD: Plasma amino acids during human spaceflight. Aviat Space Environ Med 1999; 70:250-255
90. 90. Kobayashi H, Kato H, Hirabayashi Y, et al: Modulations of muscle protein metabolism by branched-chain amino acids in normal and muscle-atrophying rats. J Nutr 2006; 136(1 Suppl):234S-236S. (Pubitemid 43156515)
91. 91. Paddon-Jones D, Sheffield-Moore M, Urban RJ, et al: Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest. J Clin Endocrinol Metab 2004; 89: 4351-4358 (Pubitemid 39244437)
92. Mondon CE, Rodnick KJ, Dolkas CB, et al: Alterations in glucose and protein metabolism in animals subjected to simulated microgravity. Adv Space Res 1992; 12: 169-177
93. Hirose M, Kaneki M, Sugita H, et al: Immobilization depresses insulin signaling in skeletal muscle. Am J Physiol Endocrinol Metab 2000; 279:E1235-E1241
94. O'Keefe MP, Perez FR, Kinnick TR, et al: Development of whole-body and skeletal muscle insulin resistance after one day of hindlimb suspension. Metabolism 2004; 53: 1215-1222
95. 95. Kim JS, Saengsirisuwan V, Sloniger JA, et al: Oxidant stress and skeletal muscle glucose transport: Roles of insulin signaling and p38 MAPK. Free Radic Biol Med 2006; 41:818-824 (Pubitemid 44163415)
96. Dong F, Hua Y, Zhao P, et al: Chromium supplement inhibits skeletal muscle atrophy in hindlimb-suspended mice. J Nutr Biochem 2008 Dec 12 [Epub ahead of print]
97. Koesterer TJ, Dodd SL, Powers S: Increased antioxidant capacity does not attenuate muscle atrophy caused by unweighting. J Appl Physiol 2002; 93:1959-1965
98. 98. Morris CA, Morris LD, Kennedy AR, et al: Attenuation of skeletal muscle atrophy via protease inhibition. J Appl Physiol 2005; 99:1719-1727 (Pubitemid 41547168)
99. Wimalawansa SM, Chapa MT, Wei JN, et al: Reversal of weightlessness- induced musculoskeletal losses with androgens: Quantification by MRI. J Appl Physiol 1999; 86: 1841-1846
100. 100. Tsika RW, Herrick RE, Baldwin KM: Effect of anabolic steroids on skeletal muscle mass during hindlimb suspension. J Appl Physiol 1987; 63:2122-2127 (Pubitemid 18016446)
101. 101. Joumaa WH, Bouhlel A, Bigard X, et al: Nandrolone decanoate pre-treatment attenuates unweighting-induced functional changes in rat soleus muscle. Acta Physiol Scand 2002; 176:301-309 (Pubitemid 35417384)
102. 102. Sugiura T, Ito N, Goto K, et al: Estrogen administration attenuates immobilization-induced skeletal muscle atrophy in male rats. J Physiol Sci 2006; 56:393-399 (Pubitemid 46974945)
103. Clemmons DR, Smith-Banks A, Underwood LE: Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab 1992; 75:234-238
104. 104. Fang CH, Li BG, Wang JJ, et al: Insulin-like growth factor 1 stimulates protein synthesis and inhibits protein breakdown in muscle from burned rats. JPEN J Parenter Enteral Nutr 1997; 21:245-251 (Pubitemid 27408641)
105. 105. Criswell DS, Booth FW, DeMayo F, et al: Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy. Am J Physiol 1998; 275:E373-E379 (Pubitemid 28436054)
106. 106. Linderman JK, Gosselink KL, Booth FW, et al: Resistance exercise and growth hormone as countermeasures for skeletal muscle atrophy in hindlimb-suspended rats. Am J Physiol 1994; 267:R365-R371 (Pubitemid 2132652)
107. Alzghoul MB, Gerrard D, Watkins BA, et al: Ectopic expression of IGF-I and Shh by skeletal muscle inhibits disuse-mediated skeletal muscle atrophy and bone osteopenia in vivo. FASEB J 2004; 18: 221-223
108. 108. Eash J, Olsen A, Breur G, et al: FGFR1 inhibits skeletal muscle atrophy associated with hindlimb suspension. BMC Musculoskelet Disord 2007; 8:32 (Pubitemid 46633724)